FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:268 January 22, 1998 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Rosenheck et al. (Sept. 18 issue)¹ reported a comparison of clozapine and haloperidol in patients hospitalized for refractory schizophrenia. They excluded patients previously treated with clozapine but not those previously treated with haloperidol. How many patients had been treated with haloperidol? What would the results show if the patients whose schizophrenia was previously known to be refractory to haloperidol were excluded?

D. Peter Birkett, M.D.
2 Copeland Dr.
Suffern, NY 10901

References

1. Rosenheck R, Cramer J, Xu W, et al. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. N Engl J Med 1997;337:809-815. [Free Full Text]

To the Editor: Our screening procedure documented that patients had been treated unsuccessfully with two neuroleptic agents, but we did not record which . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.